MRPL44 regulates lipid metabolism in metabolic dysfunction-associated steatotic liver disease through BNIP3-mediated mitophagy
This study identifies MRPL44 as a novel regulator of lipid metabolism and a potential therapeutic target for metabolic dysfunction-associated steatotic liver disease.
Authors
- Turtushikh Damba (ORCID: https://orcid.org/0000-0003-3141-249X)
- Tingli Pan
- Zhiwang Zhang (ORCID: https://orcid.org/0000-0002-0287-0224)
- Yun‐Xiao Liang (ORCID: https://orcid.org/0000-0001-9245-105X)
- Lianggui Xiao
- Changyong Sun (ORCID: https://orcid.org/0000-0001-5147-5725)
- Batbold Batsaikhan (ORCID: https://orcid.org/0000-0003-3109-2166)
- Qichao Liao
- Khongorzul Batchuluun (ORCID: https://orcid.org/0000-0001-6176-9313)
- Jiale Wang (ORCID: https://orcid.org/0000-0001-6530-7060)
- Qiuchen Cheng
- Xiangling Li (ORCID: https://orcid.org/0000-0002-8725-4040)
- Yuxin Huang (ORCID: https://orcid.org/0000-0003-3056-4168)
- Lei Zhou
- Siqi Liu (ORCID: https://orcid.org/0009-0007-9656-3930)
- Lin Yu
- Yixing Li
- Zupeng Luo
- Yang Xiao
- Yu Sun (ORCID: https://orcid.org/0000-0002-5364-2387)
- Xue Liang (ORCID: https://orcid.org/0000-0001-8269-0305)
Institutions
- Guangxi University (CN)
- Mongolian National University of Medical Sciences (MN)
- The People's Hospital of Guangxi Zhuang Autonomous Region (CN)
Publication Details
- Journal
- Frontiers in Nutrition
- Published
- 2025-10-02
- DOI
- https://doi.org/10.3389/fnut.2025.1662882
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00